Does It Really Matter What Volume to Exhale Before Using Asthma Inhalation Devices?
- Published in:
- Journal of Asthma, 2009, v. 46, n. 3, p. 212, doi. 10.1080/02770900802492087
- By:
- Publication type:
- Article
Works by Pinner, Nathan A.
Results: 15
1
2
Intravenous thrombolysis for patients with acute ischemic stroke while receiving a direct oral anticoagulant: A systematic review and meta‐analysis.
- Published in:
- Pharmacotherapy, 2025, v. 45, n. 2, p. 111, doi. 10.1002/phar.4644
- By:
- Publication type:
- Article
3
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 6, p. 526, doi. 10.1002/phar.2527
- By:
- Publication type:
- Article
4
Evaluation of Vancomycin and Gentamicin Dialysis Clearance Using In Vivo and In Vitro Systems.
- Published in:
- Renal Failure, 2012, v. 34, n. 6, p. 703, doi. 10.3109/0886022X.2012.672153
- By:
- Publication type:
- Article
5
Evaluation of a Pharmacist-Specific Intervention on 30-Day Readmission Rates for High-Risk Patients with Pneumonia.
- Published in:
- Hospital Pharmacy, 2015, v. 50, n. 8, p. 700, doi. 10.1310/hpj5008-700
- By:
- Publication type:
- Article
6
Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review.
- Published in:
- Biologics, 2024, v. 4, n. 1, p. 17, doi. 10.3390/biologics4010002
- By:
- Publication type:
- Article
7
Effect of Obesity on Clinical Failure of Patients Treated With β-Lactams.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab212
- By:
- Publication type:
- Article
8
The Impact of SGLT2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 5, p. 506, doi. 10.1177/10600280231189508
- By:
- Publication type:
- Article
9
A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 6, p. 691, doi. 10.1177/10600280211040093
- By:
- Publication type:
- Article
10
Assessment and Revision of Clinical Pharmacy Practice Internet Web Sites.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 2, p. 258, doi. 10.1177/1060028013510899
- By:
- Publication type:
- Article
11
Timing of Anticoagulation in Atrial Fibrillation Status Post Cardioembolic Stroke.
- Published in:
- Journal of Pharmacy Practice, 2020, v. 33, n. 5, p. 612, doi. 10.1177/0897190019825577
- By:
- Publication type:
- Article
12
Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2014, v. 9, p. 421, doi. 10.2147/COPD.S51012
- By:
- Publication type:
- Article
13
Tolvaptan: a vasopressin antagonist for the management of euvolemic and hypervolemic hyponatremia.
- Published in:
- Expert Review of Clinical Pharmacology, 2010, v. 3, n. 5, p. 601
- By:
- Publication type:
- Article
14
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Obesity.
- Published in:
- Journal of Pharmacy Technology, 2023, v. 39, n. 6, p. 269, doi. 10.1177/87551225231196748
- By:
- Publication type:
- Article
15
Dual Antiplatelet Therapy After an Acute Nonminor Stroke.
- Published in:
- Journal of Pharmacy Technology, 2023, v. 39, n. 2, p. 51, doi. 10.1177/87551225221145836
- By:
- Publication type:
- Article